Drug Shortage Report for MAR-TADALAFIL
Report ID | 87142 |
Drug Identification Number | 02452278 |
Brand name | MAR-TADALAFIL |
Common or Proper name | Tadalafil |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 Tablets |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2019-06-20 |
Actual start date | 2019-06-20 |
Estimated end date | 2019-08-02 |
Actual end date | 2019-07-10 |
Shortage status | Resolved |
Updated date | 2019-07-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-07-11 | French | Compare |
v4 | 2019-07-11 | English | Compare |
v3 | 2019-06-21 | English | Compare |
v2 | 2019-06-20 | French | Compare |
v1 | 2019-06-20 | English | Compare |
Showing 1 to 5 of 5